Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2003
08/20/2003EP1263504B1 Use of compounds with 5-ht1a activity useful for treating disorders of the outer retina
08/20/2003EP1212327B1 Pyrazolopyrimidines as therapeutic agents
08/20/2003EP1173434B1 Thiazolidinedione derivative and its use as antidiabetic
08/20/2003EP1165566B1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/20/2003EP1165542B1 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
08/20/2003EP1146892B1 Baff, inhibitors thereof and their use in the modulation of the b-cell response
08/20/2003EP1143968B1 Composition and methods for administration of water-insoluble paclitaxel derivatives
08/20/2003EP1086106B1 Furopyridine derivatives and their therapeutical use
08/20/2003EP1075258B1 Novel fatty analogues for the treatment of obesity
08/20/2003EP1053233B1 Hydroxamic and carboxylic acid derivatives
08/20/2003EP0900083B1 Novel substituted imidazole compounds
08/20/2003EP0697886B1 New peptide antagonists at glutamate and nmda receptors
08/20/2003CN1437653A Antigenic polypeptides
08/20/2003CN1437608A O-aryl glucoside SGL T2 inhibitors and method
08/20/2003CN1437599A Tryasolyl tropane derivatives for therapy
08/20/2003CN1437595A Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals
08/20/2003CN1437591A Compounds and methods for modulation of estrogen receptors
08/20/2003CN1437588A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type l
08/20/2003CN1437585A Method and compositions utilizing quinazolinones
08/20/2003CN1437584A Tricyclic protein kinase inhibitors
08/20/2003CN1437576A Substituted aminomethyl-phenyl-cyclohexane derivatives
08/20/2003CN1437575A Aminomethyl-phenyl-cyclohexanone derivatives
08/20/2003CN1437484A New formulation comprising a beta-blocker and optionally a cholesterol-lowering agent
08/20/2003CN1437469A Solid valsartan pharmaceutical composition
08/20/2003CN1436562A Hypericum perforatum extract and its prepn process and medicine composition
08/20/2003CN1436549A Compound Chinese medicine notoginseng dripping pills and its prepn process
08/20/2003CN1436547A Pile eliminating medicine powder
08/20/2003CN1118571C Active protein with thrombopoietin
08/20/2003CN1118475C Cyclopeptide derivatives
08/20/2003CN1118473C Aqueous soluble steroid compound alkaloid salt, producing process and medicinal composition containing same
08/20/2003CN1118468C Pyrazolopyrimidines and pyrazolotriazines
08/20/2003CN1118467C 1,3,8-triaza-spiro [4,5] decan-4-on derivatives
08/20/2003CN1118462C Substituted phenyl derivatives, producing method and use thereof
08/20/2003CN1118459C Pyrimidinedione, pyrimidi netrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha-adrenergic receptor antagonists
08/20/2003CN1118457C Cyclic diamine compound and medicine containing the same
08/20/2003CN1118454C Heterocyclic derivative and medicine
08/20/2003CN1118298C Health product instant granules and producing method thereof
08/20/2003CN1118287C Health-care medicine
08/19/2003US6608227 Benzylcycloalkyl amines as modulators of chemokine receptor activity
08/19/2003US6608210 Benzimidazole derivatives, their production and use
08/19/2003US6608203 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
08/19/2003US6608182 Human vascular endothelial growth factor 2
08/19/2003US6608107 Administering gossypol; kits to treat patients
08/19/2003US6608106 Contacting the cell with an amount of dehydroascorbic acid effective to increase the concentration of ascorbic acid in the cell
08/19/2003US6608104 Gem substituted hydroxamic acids
08/19/2003US6608103 Inhibitor for neovasculation, cell multiplication, lumen formation and FGF
08/19/2003US6608101 1, 3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
08/19/2003US6608099 Indole sPLA2 inhibitors
08/19/2003US6608097 Materials and methods for the treatment of hypertension and angina
08/19/2003US6608077 Il-8 receptor antagonists
08/19/2003US6608069 Phenyl xanthine derivatives
08/19/2003US6608066 Tissue factor antagonists and methods of use thereof
08/19/2003US6608063 For example: (2-(3-amino-4-nitrophenyl)amino)ethyl)(6-(2,4-dichlorophenyl-5-nitropyrazin -2-yl)-amine; antidiabetic, -carcingenic and ischemic agents; nervous and cardiovascular system disorders; immunotherapy; obesity; syndromes
08/19/2003US6608057 Compounds useful as reversible inhibitors of cathepsin S
08/19/2003US6608044 Inhibition of TNF activity
08/19/2003US6608032 Medicinal compositions
08/19/2003US6608031 Peptide comprising specified amino acid sequence
08/19/2003US6607882 Regulation of endogenous gene expression in cells using zinc finger proteins
08/19/2003US6607730 Chlamydia antigens and corresponding DNA fragments and uses thereof
08/19/2003CA2276324C Loratadine for use as an antiarrhythmic
08/19/2003CA2260337C Therapeutic agents
08/19/2003CA2099061C Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
08/19/2003CA2079376C (bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
08/19/2003CA2043077C Prostaglandin analogues for use in medicine
08/14/2003WO2003066881A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/14/2003WO2003066859A2 Amino acid sequences capable of facilitating penetration across a biological barrier
08/14/2003WO2003066842A2 Method for producing recombinant proteins in micro-organisms
08/14/2003WO2003066840A2 Pluripotent embryonic-like stem cells derived from teeth and uses thereof
08/14/2003WO2003066824A2 Albumin-fused kunitz domain peptides
08/14/2003WO2003066822A2 Truncated aggrecanase molecules
08/14/2003WO2003066813A2 MINRs AS MODIFIERS OF INSULIN RECEPTOR SIGNALING AND METHODS OF USE
08/14/2003WO2003066672A1 Peptides
08/14/2003WO2003066636A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/14/2003WO2003066630A2 Quinolinone derivatives for treating cell proliferation related disorders
08/14/2003WO2003066629A2 Heteroaryl compounds useful as inhibitors of gsk-3
08/14/2003WO2003066627A1 Deuterated spirocyclopentanimidazolinones and the use thereof in the treatment of cardiovascular diseases
08/14/2003WO2003066626A1 Deuterated biphenyl-substituted benzimidazoles and medicament containing said compounds for the treatment of hypertonia
08/14/2003WO2003066621A1 Piperidine derivatives and their use as antagonists of tachykinins
08/14/2003WO2003066620A1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent
08/14/2003WO2003066618A1 Cytoprotective benzofuran derivatives
08/14/2003WO2003066608A1 Catechol bioisosteres
08/14/2003WO2003066606A1 Salts of valsartan
08/14/2003WO2003066601A1 Pyrimidine compounds
08/14/2003WO2003066599A1 N-allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use of the same as pharmaceuticals
08/14/2003WO2003066595A2 2 - piperazine - pyridines useful for treating pain
08/14/2003WO2003066594A2 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
08/14/2003WO2003066591A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
08/14/2003WO2003066590A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
08/14/2003WO2003066589A1 Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
08/14/2003WO2003066588A1 Water soluble phenylglycine derivatives
08/14/2003WO2003066577A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
08/14/2003WO2003066205A2 Microcapsules having high carotenoid content
08/14/2003WO2003066087A2 Kinases involved in the regulation of energy homeostasis
08/14/2003WO2003066085A1 Albumin-fused anti-angiogenesis peptides
08/14/2003WO2003066082A1 Use of the insulin-like-growth factor i splice variant mgf for the prevention of myocardial damage
08/14/2003WO2003066078A1 Hiv inhibiting proteins
08/14/2003WO2003066077A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
08/14/2003WO2003066071A1 Formulations comprising psychotropic drugs and selenium
08/14/2003WO2003066067A2 Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
08/14/2003WO2003066057A1 Quinoxalinones and their use especially in the treatment of cardiovascular diseases
1 ... 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 ... 1595